The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells

Experimental Cell Research

Volumn 314, Issue 17, 2008, Pages 3107-3117

  Lin, Siang Yo ^a,b   Yang, Jun ^a,b   Everett, Allen D ^a,b   Clevenger, Charles V ^b,c   Koneru, Mythili ^a,b   Mishra, Pravin J ^a,b   Kamen, Barton ^a,b   Banerjee, Debabrata ^a,b   Glod, John ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemotaxis; Mesenchymal stromal cell; Tumor microenvironment

Indexed keywords

CYCLOPHILIN B; HEPATOMA DERIVED GROWTH FACTOR;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CHEMOTAXIS; CHROMATOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; STROMA CELL; TANDEM MASS SPECTROMETRY;

EID: 53049105636     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.07.028     Document Type: Article

References (53)

1. Friedenstein A.J., Chailakhjan R.K., and Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell. Tissue Kinet. 3 (1970) 393-403
2. Luria E.A., Panasyuk A.F., and Friedenstein A.Y. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 11 (1971) 345-349
3. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
4. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., and Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4 (1998) 415-428
5. He Q., Wan C., and Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25 (2007) 69-77
6. Rochefort G.Y., Delorme B., Lopez A., Herault O., Bonnet P., Charbord P., Eder V., and Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24 (2006) 2202-2208
7. Kassis I., Zangi L., Rivkin R., Levdansky L., Samuel S., Marx G., and Gorodetsky R. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant. 37 (2006) 967-976
8. Fernandez M., Simon V., Herrera G., Cao C., Del Favero H., and Minguell J.J. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant. 20 (1997) 265-271
9. Kim S.J., Cho H.H., Kim Y.J., Seo S.Y., Kim H.N., Lee J.B., Kim J.H., Chung J.S., and Jung J.S. Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochem. Biophys. Res. Commun. 329 (2005) 25-31
10. Miao Z., Jin J., Chen L., Zhu J., Huang W., Zhao J., Qian H., and Zhang X. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell. Biol. Int. 30 (2006) 681-687
11. Shen F.H., Visger J.M., Balian G., Hurwitz S.R., and Diduch D.R. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J. Orthop. Trauma. 16 (2002) 651-659
12. McFarlin K., Gao X., Liu Y.B., Dulchavsky D.S., Kwon D., Arbab A.S., Bansal M., Li Y., Chopp M., Dulchavsky S.A., and Gautam S.C. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen. 14 (2006) 471-478
13. Boomsma R.A., Swaminathan P.D., and Geenen D.L. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int. J. Cardiol. 122 (2007) 17-28
14. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., and Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 62 (2002) 3603-3608
15. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreeff M., and Lang F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer. Res. 65 (2005) 3307-3318
16. Xin H., Kanehira M., Mizuguchi H., Hayakawa T., Kikuchi T., Nukiwa T., and Saijo Y. Targeted-delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25 (2007) 1618-1626
17. Bhakta S., Hong P., and Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc. Revasc. Med. 7 (2006) 19-24
18. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., and Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104 (2004) 2643-2645
19. Schichor C., Birnbaum T., Etminan N., Schnell O., Grau S., Miebach S., Aboody K., Padovan C., Straube A., Tonn J.C., and Goldbrunner R. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp. Neurol. 199 (2006) 301-310
20. Fiedler J., Etzel N., and Brenner R.E. To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J. Cell. Biochem. 93 (2004) 990-998
21. Wang L., Li Y., Chen X., Chen J., Gautam S.C., Xu Y., and Chopp M. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7 (2002) 113-117
22. Menon L.G., Picinich S., Koneru R., Gao H., Lin S.Y., Koneru M., Mayer-Kuckuk P., Glod J., and Banerjee D. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25 (2007) 520-528
23. Webb L.M., Ehrengruber M.U., Clark-Lewis I., Baggiolini M., and Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7158-7162
24. Wang L., Fuster M., Sriramarao P., and Esko J.D. Endothelial heparan sulfate deficiency impairs l-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6 (2005) 902-910
25. Veldkamp C.T., Peterson F.C., Pelzek A.J., and Volkman B.F. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci. 14 (2005) 1071-1081
26. Rycyzyn M.A., and Clevenger C.V. Role of cyclophilins in somatolactogenic action. Ann. N. Y. Acad. Sci. 917 (2000) 514-521
27. Rycyzyn M.A., Reilly S.C., O'Malley K., and Clevenger C.V. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol. Endocrinol. 14 (2000) 1175-1186
28. Yang J., and Everett A.D. Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain. BMC Mol. Biol. 8 (2007) 101
29. Allain F., Vanpouille C., Carpentier M., Slomianny M.C., Durieux S., and Spik G. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2714-2719
30. Pakula R., Melchior A., Denys A., Vanpouille C., Mazurier J., and Allain F. Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis. Glycobiology 17 (2007) 492-503
31. Sherry B., Yarlett N., Strupp A., and Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3511-3515
32. Xu Q., Leiva M.C., Fischkoff S.A., Handschumacher R.E., and Lyttle C.R. Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267 (1992) 11968-11971
33. Narron J.V., Stoops T.D., Barringhaus K., Matsumura M., and Everett A.D. Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration. Pediatr. Res. 59 (2006) 778-783
34. Everett A.D., Lobe D.R., Matsumura M.E., Nakamura H., and McNamara C.A. Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J. Clin. Invest. 105 (2000) 567-575
35. Everett A.D., Stoops T., and McNamara C.A. Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells. J. Biol. Chem. 276 (2001) 37564-37568
36. Yurchenko V., O'Connor M., Dai W.W., Guo H., Toole B., Sherry B., and Bukrinsky M. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun. 288 (2001) 786-788
37. Sadir R., Imberty A., Baleux F., and Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J. Biol. Chem. 279 (2004) 43854-43860
38. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1885-1890
39. Netelenbos T., Zuijderduijn S., Van Den Born J., Kessler F.L., Zweegman S., Huijgens P.C., and Drager A.M. Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J. Leukoc. Biol. 72 (2002) 353-362
40. Kuschert G.S., Coulin F., Power C.A., Proudfoot A.E., Hubbard R.E., Hoogewerf A.J., and Wells T.N. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38 (1999) 12959-12968
41. Wang P., and Heitman J. The cyclophilins. Genome Biol. 6 (2005) 226
42. Everett A.D., Narron J.V., Stoops T., Nakamura H., and Tucker A. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L1194-1201
43. Okuda Y., Nakamura H., Yoshida K., Enomoto H., Uyama H., Hirotani T., Funamoto M., Ito H., Everett A.D., Hada T., and Kawase I. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Sci. 94 (2003) 1034-1041
44. Handel T.M., Johnson Z., Crown S.E., Lau E.K., and Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 74 (2005) 385-410
45. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., and Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36 (1997) 13570-13578
46. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., and Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91 (1997) 385-395
47. Ellyard J.I., Simson L., Bezos A., Johnston K., Freeman C., and Parish C.R. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J. Biol. Chem. 282 (2007) 15238-15247
48. Sweeney E.A., Lortat-Jacob H., Priestley G.V., Nakamoto B., and Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 99 (2002) 44-51
49. Dias-Baruffi M., Pereira-da-Silva G., Jamur M.C., and Roque-Barreira M.C. Heparin potentiates in vivo neutrophil migration induced by IL-8. Glycoconj. J. 15 (1998) 523-526
50. Shaked Y., Ciarrocchi A., Franco M., Lee C.R., Man S., Cheung A.M., Hicklin D.J., Chaplin D., Foster F.S., Benezra R., and Kerbel R.S. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313 (2006) 1785-1787
51. Mancuso P., Colleoni M., Calleri A., Orlando L., Maisonneuve P., Pruneri G., Agliano A., Goldhirsch A., Shaked Y., Kerbel R.S., and Bertolini F. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood 108 (2006) 452-459
52. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., and Schwendener R.A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer. 95 (2006) 272-281
53. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., and Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563